LeonaBio
Drug Discovery
LeonaBio valuation and funding history | Last updated: June 4, 2020 | 2 funding rounds
Current Valuation
N/A
As of June 4, 2020
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series B)
$85.0M
Last Funding
Jun 2020
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| June 4, 2020 | Later Stage VC (Series B) | $85.0M | N/A | - |
| January 1, 2018 | Accelerator/Incubator | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
LeonaBio is currently valued at N/A as of June 4, 2020.
What is LeonaBio Worth in 2026?
LeonaBio is a leading private company in the Drug Discovery sector. Track LeonaBio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How LeonaBio Valuation is Determined
Private company valuations like LeonaBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.